Skip to main content

Advertisement

Log in

Value of hyperbaric oxygen in bacterial and fungal malignant external otitis treatment

  • Miscellaneous
  • Published:
European Archives of Oto-Rhino-Laryngology and Head & Neck Aims and scope Submit manuscript

Abstract

Malignant external otitis (MEO) is an invasive, morbidity, even mortality, mainly pseudomonal infection of the external auditory canal, frequently involving the base of the skull, multiple cranial nerve and the meninges. In many cases conventional therapy has been prolonged, intensive and relatively ineffective, especially in infections other than bacterial (mainly fungal). We presented theoretical principles of hyperbaric oxygen (HBO) treatment in MEO, our own experience and others’ experience in applying this treatment method. We treated eight patients with MEO applying pharmacotherapy, topical management, surgery in one case and also adjunct HBO. In six patients, infection was caused by Pseudomonas aeruginosa, in one by Staphylococcus sp. and in one by Aspergillus sp. Complete recovery was achieved in seven patients. In the patient with MEO caused by Aspergillus sp., intracranial complications developed and the patient died. Our experiences in employing HBO in bacterial-caused MEO have confirmed the role of HBO as a valuable, beneficial, supporting classical treatment method. Small number of patients with MEO, especially with non-bacterial infection, and unforeseen clinical course of disease make our experience difficult to objectivize.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Chandler JR (1968) Malignant external otitis. Laryngoscope 78:1257–1294

    Article  PubMed  CAS  Google Scholar 

  2. Davis JC, Gates GA, Lerner C, Davis MG, Mader JT, Dinesman A (1992) Adjuvant hyperbaric oxygen in malignant external otitis. Arch Otolaryngol Head Neck Surg 118:89–93

    PubMed  CAS  Google Scholar 

  3. Meltzer PE, Kelemen G (1959) Pyocyaneous osteomyelitis of the temporal bone, mandible and zygoma. Laryngoscope 69:1300–1316

    Article  Google Scholar 

  4. Ruben Grandis J, Branstetter BF, Yu VL (2004) The changing face of malignant (necrotising) external otitis: clinical, radiological, and anatomic correlations. Lancet Inf Dis 4:34–39

    Article  Google Scholar 

  5. Shelton JC, Antonelli PJ, Hackett R (2002) Skull base fungal osteomyelitis in an immunocompetent host. Otolaryngol Head Neck Surg 126:76–78

    Article  PubMed  Google Scholar 

  6. Sreepada GS, Kwartler JA (2003) Skull base osteomyelitis secondary to malignant otitis externa. Curr Opin Otolaryngol Head Neck Surg 11:316–323

    Article  PubMed  Google Scholar 

  7. Granström G, Hanner P, Edebo L, Fornander J (1990) Malignant external otitis caused by Pseudoallescheria boydii. Treatment with hyperbaric oxygenation. In: Proceedings 1h EUBS Congress. Amsterdam, pp 41–49

  8. Menchof MR, Jackler RK (1990) Otogenic skull base osteomyelitis caused by invasive fungal infection. Otolaryng Head Neck Surg 102:285–289

    Google Scholar 

  9. Kountakis SE, Kemper JV, Chang CYJ, Di Maio DJ, Stiernberg CM (1997) Osteomyelitis of the base of the skull secondary to Aspergillus. Am J Otolaryngol 18: 19–22

    Article  PubMed  CAS  Google Scholar 

  10. Yao M, Messner AH (2001) Fungal malignant otitis externa due to Scedosporium apiospermum. Ann Otol Rhinol Laryngol 110:377–380

    PubMed  CAS  Google Scholar 

  11. Petrak RM, Pottage JC, Levin S (1985) Invasive external otitis caused by Aspergillus fumigatus in an immunocompromised host. J Infect Dis 151:196

    Google Scholar 

  12. Finer G, Greenberg D, Leibovitz E, Leiberman A, Shelef I, Kapelushnik J (2002) Conservative treatment of malignant (invasive) external otitis caused by Aspergillus flavus with oral itraconazole solution in neutropenic patient. Scand J Infect Dis 34:227–229

    Article  PubMed  Google Scholar 

  13. Bellini C, Antonini P, Ermanni S, Dolina M, Passega E, Bernasconi E (2003) Malignant otitis externa due Aspergillus niger. Scand J Infect Dis 35:284–288

    Article  PubMed  CAS  Google Scholar 

  14. Handzel O, Halperin D (2003) Necrotizing (malignant) external otitis. Am Fam Phys 15:309–312

    Google Scholar 

  15. Levenson MJ, Parisier SC, Dolitsky J, Bindra G (1991) Ciprofloxacin: drug of choice in the treatment of malignant external otitis. Laryngoscope 101:821–824

    Article  PubMed  CAS  Google Scholar 

  16. Grandis JR, Curton HD, Yu VL (1995) Necrotizing (malignant) external otitis: prospective comparison of CT and MRI imaging in diagnosis and follow-up. Radiology 196:499–504

    PubMed  CAS  Google Scholar 

  17. Mader JT, Love JT (1982) Malignant external otitis. Cure with adjunctive hyperbaric oxygen therapy. Arch Otolaryngol 108:38–40

    PubMed  CAS  Google Scholar 

  18. Pilgramm M, Frey G, Schumann K (1986) Hyperbare Oxygenation eine sinvolle Zusatztherapie bei Otitis Externa Maligna. Laryngol Rhinol Otol 65:26–28

    Article  CAS  Google Scholar 

  19. Shupak A, Greenberg E, Hardoff R, Gordon C, Melamid Y, Meyer WS (1989) Hyperbaric oxygenation for necrotizing (malignant) otitis externa. Arch Otolaryngol Head Neck Surg 115:1470–1475

    PubMed  CAS  Google Scholar 

  20. Vernick DM (1993) Malignant external otitis. In: Nadol JB, Schuknecht HF (eds) Surgery of the ear and temporal bone. Raven Press, New York, pp 199–203

  21. Berenholz L, Katzenell U, Harell M (2002) Evolving resistant pseudomonas to ciprofloxacin in malignant otitis externa. Laryngoscope 112:1619–1622

    Article  PubMed  CAS  Google Scholar 

  22. Tisch M, Lorenz M, Lampl L, Maier H (2003) Otitis externa necroticans. HNO 51:315–320

    Article  PubMed  CAS  Google Scholar 

  23. Lucente FE, Parisier SC, Som PM (1983) Complications of the treatment of malignant external otitis. Laryngoscope 93: 279–281

    Article  PubMed  CAS  Google Scholar 

  24. Jain KK (1999) Textbook of hyperbaric medicine, 3rd edn. Hogrefe & Huber Publishers, Seattle

    Google Scholar 

  25. Verklin RM, Mandel GL (1977) Alteration of effectiveness of antibiotics by anerobiosis. J Lab Clin Med 80:65–71

    Google Scholar 

  26. Kirby SD, Deschler DG (1999) Hyperbaric oxygen therapy: application in diseases of the head and neck. Curr Opin Otolaryngol Head Neck Surg 7:137–143

    Article  Google Scholar 

  27. Tos M (1997) Malignant otitis externa. In: Tos M (ed) Manual of middle ear surgery, vol 3. Surgery of the external auditory canal. Thieme, Stuttgart, pp 241–246

  28. Caldwell J (1963) Effects of high partial pressures of oxygen on fungi. Nature 19:772–774

    Article  Google Scholar 

  29. Robb SM (1966) Reactions of fungi to exposure to ten atmospheres of pressure of oxygen. J Gen Microbiol 45:17–23

    Google Scholar 

  30. Price JC, Stevens DL (1980) Hyperbaric oxygenation in the treatment of rhinocerebral mucoromycosis. Laryngoscope 90:737–747

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Waldemar Narozny.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Narozny, W., Kuczkowski, J., Stankiewicz, C. et al. Value of hyperbaric oxygen in bacterial and fungal malignant external otitis treatment. Eur Arch Otorhinolaryngol 263, 680–684 (2006). https://doi.org/10.1007/s00405-006-0033-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-006-0033-y

Keywords

Navigation